Stryker Corporation (NYSE:SYK) Shares Sold by Tokio Marine Asset Management Co. Ltd.

Tokio Marine Asset Management Co. Ltd. reduced its position in Stryker Corporation (NYSE:SYK) by 24.5% during the first quarter, according to its most recent 13F filing with the SEC. The fund owned 4,791 shares of the medical technology company’s stock after selling 1,554 shares during the period. Tokio Marine Asset Management Co. Ltd.’s holdings in Stryker Corporation were worth $631,000 as of its most recent filing with the SEC.

Other institutional investors have also modified their holdings of the company. Bollard Group LLC boosted its position in shares of Stryker Corporation by 0.4% in the first quarter. Bollard Group LLC now owns 829 shares of the medical technology company’s stock worth $109,000 after buying an additional 3 shares during the last quarter. Assetmark Inc. raised its stake in shares of Stryker Corporation by 0.3% in the first quarter. Assetmark Inc. now owns 1,274 shares of the medical technology company’s stock worth $168,000 after buying an additional 4 shares during the period. Blue Chip Partners Inc. raised its stake in shares of Stryker Corporation by 0.3% in the first quarter. Blue Chip Partners Inc. now owns 1,775 shares of the medical technology company’s stock worth $234,000 after buying an additional 6 shares during the period. Baystate Wealth Management LLC raised its stake in shares of Stryker Corporation by 2.1% in the first quarter. Baystate Wealth Management LLC now owns 1,066 shares of the medical technology company’s stock worth $139,000 after buying an additional 22 shares during the period. Finally, BKD Wealth Advisors LLC raised its stake in shares of Stryker Corporation by 1.1% in the first quarter. BKD Wealth Advisors LLC now owns 3,356 shares of the medical technology company’s stock worth $442,000 after buying an additional 35 shares during the period. Institutional investors own 74.26% of the company’s stock.

Stryker Corporation (SYK) traded up 2.60% during trading on Friday, hitting $147.80. 1,927,066 shares of the company’s stock were exchanged. Stryker Corporation has a 12-month low of $106.48 and a 12-month high of $148.15. The firm has a market cap of $55.26 billion, a price-to-earnings ratio of 32.99 and a beta of 0.79. The company’s 50-day moving average price is $142.41 and its 200 day moving average price is $133.92.

Stryker Corporation (NYSE:SYK) last posted its earnings results on Thursday, July 27th. The medical technology company reported $1.53 earnings per share for the quarter, beating the consensus estimate of $1.51 by $0.02. The firm had revenue of $3.01 billion during the quarter, compared to analyst estimates of $2.98 billion. Stryker Corporation had a net margin of 14.22% and a return on equity of 24.58%. The business’s quarterly revenue was up 6.1% on a year-over-year basis. During the same period in the previous year, the firm earned $1.39 EPS. Equities analysts forecast that Stryker Corporation will post $6.43 earnings per share for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Monday, July 31st. Stockholders of record on Friday, June 30th will be issued a dividend of $0.425 per share. This represents a $1.70 annualized dividend and a dividend yield of 1.15%. The ex-dividend date of this dividend is Wednesday, June 28th. Stryker Corporation’s dividend payout ratio (DPR) is 37.95%.

COPYRIGHT VIOLATION WARNING: This story was reported by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are accessing this story on another site, it was stolen and reposted in violation of US & international copyright legislation. The original version of this story can be read at https://www.chaffeybreeze.com/2017/07/30/tokio-marine-asset-management-co-ltd-has-631000-position-in-stryker-corporation-nysesyk-updated-updated-updated.html.

A number of equities research analysts have issued reports on SYK shares. Deutsche Bank AG reissued a “buy” rating and issued a $148.00 price target (up previously from $135.00) on shares of Stryker Corporation in a report on Saturday, April 29th. BidaskClub lowered shares of Stryker Corporation from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, June 13th. Zacks Investment Research raised shares of Stryker Corporation from a “hold” rating to a “buy” rating and set a $163.00 target price on the stock in a research note on Monday, July 17th. Stifel Nicolaus lifted their target price on shares of Stryker Corporation from $151.00 to $158.00 and gave the company a “buy” rating in a research note on Friday. Finally, Cowen and Company reaffirmed a “buy” rating and set a $160.00 target price on shares of Stryker Corporation in a research note on Sunday. Three research analysts have rated the stock with a sell rating, seven have given a hold rating and twelve have given a buy rating to the stock. The company has a consensus rating of “Hold” and a consensus price target of $143.87.

In other news, insider David Floyd sold 7,381 shares of Stryker Corporation stock in a transaction that occurred on Monday, June 5th. The shares were sold at an average price of $144.70, for a total transaction of $1,068,030.70. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Timothy J. Scannell sold 13,322 shares of Stryker Corporation stock in a transaction that occurred on Tuesday, May 2nd. The shares were sold at an average price of $135.89, for a total transaction of $1,810,326.58. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 40,008 shares of company stock valued at $5,669,088. Insiders own 7.40% of the company’s stock.

Stryker Corporation Company Profile

Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company’s segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products.

Institutional Ownership by Quarter for Stryker Corporation (NYSE:SYK)

Receive News & Ratings for Stryker Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply